Picture this: you're battling heart failure and meeting with your doctor to discuss treatment. Before prescribing anything, the doctor pulls up a virtual model of your heart on her computer and "treats" it with several drugs. A few moments later, she can see how your heart is doing five years down the road.

Your doctor chooses the treatment with the best long-term outcome, and you live a longer and healthier life.

Two University of Kentucky researchers are working to make this experience a reality for the 5.7 million adults in the U.S. with heart failure.

Why do some people stay intellectually sharp into their 90s, while others have memory problems?  Is there anything we can learn from their lifestyles that can help everyone age successfully?

These are among topics scheduled for the University of Kentucky Sanders-Brown Center on Aging's Markesbery Symposium on Nov. 3-4.  Keynote speakers are:

University of Kentucky President Eli Capilouto, UK Executive Vice President for Health Affairs Dr. Mark F. Newman, Lexington Mayor Jim Gray, Dr. John Fowlkes, director of the Barnstable Brown Diabetes Center, and members of the Barnstable Brown family will participate in a ribbon-cutting ceremony for the newly expanded Barnstable Brown Diabetes Center at UK HealthCare’s Turfland location and celebration of the recent U.S. News and World Report National ranking placing the Barnstable Brown Center in the top 50 for endocrinology and diabetes care.

 University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.

The National Institutes of Health has awarded a five year, $2.88 million grant to a Sanders-Brown Center on Aging researcher to study a drug's potential to prevent Alzheimer's disease.

A fundraising effort that began with an impassioned plea from one extension homemaker to her peers has positively impacted Kentucky women and the University of Kentucky for the past 40 years.

Of the 14 million cancer survivors in the United States, a significant number experience a serious side effect called chemotherapy-induced cognitive impairment (CICI). While easily recognized, little is known about the etiology of this condition, also known informally as “chemo brain.” CICI can significantly reduce patients’ quality of life with serious, even devastating, symptoms such as memory lapses, difficulty concentrating, negative impacts on multitasking, confusion and fatigue.

Physicians at the University of Kentucky Markey Cancer Center are the first to perform a unique procedure to treat a rare and persistent type of ovarian cancer. Surgical oncologist Dr. Lauren Baldwin and radiation oncologist Dr. Jonathan Feddock collaborated on the procedure, which involved resecting the tumor and installing a special internal radiation device known as a CivaSheet. For nearly three decades, the patient who underwent the procedure has been living with a rare type of slow-growing ovarian cancer. Multiple rounds of chemotherapy and radiation failed to stop the disease.

Medical residents from the University of Kentucky Department of Otolaryngology – Head and Neck Surgery recently won the 2017 American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) Academic Quiz Bowl at the AAO-HNS Annual Meeting held in Chicago Sept.10 to 13.

St. Elizabeth Healthcare has provided a gift of $2.5 million to support a tuition scholarship program for the University of Kentucky College of Medicine in Northern Kentucky. Through this gift, scholarships will be awarded to medical students enrolled at the Northern Kentucky campus, which is scheduled to open in the fall of 2019.

The affiliation between the University of Kentucky, Northern Kentucky University and St. Elizabeth Healthcare was announced in February. This scholarship program is the next step in the development of a regional medical college in Northern Kentucky.

University of Kentucky and UK HealthCare employees will gather today to honor the career and leadership of UK Executive Vice President for Health Affairs Dr. Michael Karpf as he prepares to complete his last week in the role he has held for the past 14 years. Dr. Mark Newman will begin his post as the new EVPHA beginning Sept. 18. "It’s a pleasure to honor an individual who has so deeply impacted our campus and our Commonwealth," said UK President Eli Capilouto.

Last month, the UK HealthCare ALS Clinic earned a coveted recognition from the ALS Association: ALS Association Certified Treatment Center of Excellence. The certification honors UK's commitment to ALS research and patient care, which centers around a multidisciplinary approach where ALS patients see a variety of specialists in a single visit.

(Read more about our ALSA Certification here.)

In a paper published in the Journal of Alzheimer's Disease, lead author Eseosa Ighodaro, Ph.D., encouraged fellow researchers to address the challenges associated with studying dementia in Blacks/African-Americans. The paper, co-authored by researchers at the University of Kentucky's Sanders-Brown Center on Aging, the University of Washington, Rice University and Rush University Medical Center, is a clear-eyed look at the barriers that hinder minority recruitment for dementia research and the misconceptions that potentially distort research outcomes through unintended bias.

The NIH Center of Biomedical Research Excellence (COBRE) on Obesity and Cardiovascular Diseases, in collaboration with the Center for Clinical and Translational Sciences (CCTS) announce the availability of limited funds to support pilot projects focused on research examining obesity-associated diseases (cardiovascular, diabetes, others). These pilot grants are intended to assist investigators new to this area of research to generate sufficient data to be competitive for extramural funding.

Funding Amount:

Everyday, approximately 15 people learn they have Amyotrophic Lateral Sclerosis. ALS is a progressive neurological disease that affects the nerve cells in the brain and the spinal cord, eventually stealing from its victims the ability to walk, dress, write, speak, swallow and breathe. Most ALS patients die within five years of diagnosis, and currently, there is no cure.

UK HealthCare’s University of Kentucky Albert B. Chandler Hospital remains the No. 1 hospital in Kentucky and the Bluegrass Region, according to the U.S. News & World Report's Best Hospitals Rankings released today.

In addition, four major health care areas have achieved top 50 national rankings, three of them for the first time. UK HealthCare rankings included: #50 in Cancer, #44 in Neurology and Neurosurgery, #43 in Geriatrics, and #37 in Diabetes and Endocrinology.

A new study by University of Kentucky Markey Cancer Center researchers shows that when therapy-sensitive cancer cells die, they release a "killer peptide" that can eliminate therapy-resistant cells.

Tumor relapse is a common problem following cancer treatment, because primary tumor cells often contain therapy-resistance cancer cells that continue to proliferate after the therapy-sensitive cells have been eliminated.

By Vice President for Research Lisa Cassis Thursday

In May, it was my distinct pleasure to present Matthew Gentry with a University Research Professorship award. He was one of 16 faculty, selected by their own colleges, who have demonstrated excellence in scholarship and creative work that addresses scientific, social, cultural and economic challenges in our region and around the world.

Dr. Jing Li has been named associate director of the University of Kentucky Center for Health Services Research and the new director of the Office of Value and Innovation in Healthcare Delivery (OVIHD). Li graduated from Tianjin Medical University and completed residency training in anesthesiology and subsequent clinical research training at its hospital.